¡¡ Registration
  Registration
  Hotel Info
  Tech Tour
  For Accompanies
  Food Preferences
 ¡¡ IDDST 2008
  General Information
  Tracking Record
  Organizers & SAB
  Agenda
  Keynote Lectures
  Pre/Post-Conference
  Scientific Program
  Key Dates
  About the Venue
  Online Broadcasting Tool
 ¡¡ For Speakers
  Why Speak?
  Oral Presentations
  Abstracts & Biography
¡¡ For Exhibitors
  Exhibitors
  Media Partners
  Posters
  Job Posting
 ¡¡ For Sponsors
  Who Should Sponsor?
  Sponsorship Options
 ¡¡ For Attendees
  Group Participants
  Individuals
  Invitation and Visa
 ¡¡ Business Development
  Innovators
  Investors
  Market Expansion
  Advertisement
  Outsourcing
 ¡¡ Beijing and Xian
  Olympic City-Beijing
  Culture City-X'ian
  Transportation
  Weather
  Photo Gallery
  ¡¡Additional Information
  Call for Co-Organizers
  Help & FQA
  Send Feedback
 ¡¡ BIT's upcoming events
 
 
2008 iBio
(May 18-22, 2008,Hangzhou,China)
CEMD-2008
( Oct.22-28, 2008, Beijing & Xi'an, China )
WCV 2008
( Dec.1-5, 2008, Guangzhou, China)
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China)
 
 
Scientific Program

    Congress Dates : October 18-22, 2008     Beijing Loong Palace Hotel & Resort, Beijing
    Exhibition Dates : October 18-20, 2008


2008 IDDST Tentative Program

Time: October 18-22, 2008

Venue: Loong Palace Hotel, Beijing, China

 

Morning of October 18


Opening Ceremony & Keynote Forum

For Detail Track Info: Click here



Morning of October 19


Plenary Lectures

-- From Novel Targets to Billion Dollar Molecules

Special Symposium Sponsored by ACS-Medichem Division



Afternoon of October 18, Afternoon of October 19


Track 1: Applicable and Frontier Scientific Methodologies and Models

-Great Thoughts for Deciphering Human Disorders

For Detail Track Info: Click here, Session 1-20


Morning of October 20


Track 2: How Advanced Medicinal Chemistry Help Your prototype molecules to Blockbusters

-Listen to Successful Case Story from Big Phmarmas and Enjoy the Voice of ACS Medichem

For Detail Track Info: Click here, Session 21-25



Morning of October 20


Track 3: Translational Cutting-Edge Technologies

-Speeding Discovery Process with Niches

For Detail Track Info:
Click here, Session 26-35



Morning of October 20, Afternoon of October 21, Morning of October 22


Track 4: Therapeutics Development for Major and Rare Diseases

-Delivering Promises for Future Drugs

For Detail Track Info: Click here, Session 36-55



Morning of October 22


Track 5:: Nature Product Based Drug Discovery

-Mining 5000 Year Nature Pool

For Detail Track Info: Click here, Session 56-60



Morning of October 22


Track 6: Drug R & D Partnering in China

-Integrating Resources and Talents from the East To Slow Your Money Burning Rate Increase pipeline successful percentage

For Detail Track Info: Click here, Session 61-65

Time

Activities

Oct.18, 2008
Saturday
08:20-12:10

Opening Ceremony

08:20-08:40

Group Photo

09:00-09:05

Chair's Opening Remark
09:05-09:35

VIP's Address

Keynote Forum

09:40-10:05

Title: The Secret Life of Enzymes

Prof. K. Barry Sharpless, 2001 Nobel Laureate in Chemistry, The Scripps Research Institute, USA

10:05-10:30

Title: Innovation in Drug Discovery

Dr. Joel C Barrish, Vice President, Immunology and Metabolic Diseases Chemistry, Bristol-Myers Squibb, USA
10:30-10:55

Title: TBD

Dr. Andreas Tschirky, Roche's Head of R&D in China
10:55-11:20

Reserved for Domestic Expert

11:20-11:45

Title: Evolution of Influenza via Recombination, with Emphasis on H5N1 and Vaccine Target Development

Dr. Henry L. Niman, President, Founder, Recombinomics, Inc. USA
11:45-12:10

Reserved for Industrial Leader (Available for Sponsorship)


The Main Scientific Program will take place from 09:00-17:00 during October 18-22, 2008. 500+ Research and Industrial Presentations divided into six tracks with sixty-five sessions in total. The ten sessions offered will run concurrently per half day.

Click following session number for detailed program:

 

Track 1: Drug Discovery Sciences ¡øTOP
-Great Thoughts for Deciphering Human Disorders
 

Time

Sessions

Oct.18, 2008
Saturday
13:30-17:30

Session 1: ¡°-Omics¡±, Molecular Genetics to System Biology and Drug Discovery

Session Chair:

Dr. Christian Pasquali, Professor, Geneva Research Center, Merck Serono International S.A., Switzerland

Co-Chair:

Dr. Guochun Liao, Group Leader, Roche Pharmaceuticals, USA
13:30-13:55

Title: Principals for Omic Medicine

Dr. Ira L. Goldknopf,
Director of Proteomics, Power3 Medical Products, Inc., USA

13:55-14:20

Title: System Biology, Gene Biomarker in Preclinical Drug Development

Dr. Ying Jiang, Research Fellow Merck & Co., Inc.

14:20-14:45

Title: TBD

Dr. Anuradha Acharya
, Founder and CEO, Ocimum Biosolutions, USA

14:45-15:10

Title: The Use of Support Vector Machine (SVM) Technology to Develop Molecular Diagnostic Tests

Dr. Stephen D. Barnhill, Chairman and Chief Executive Officer, Health Discovery Corporation, USA

15:10-15:25 Coffee Break
15:25-15:50

Title: A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in Macrophages

Dr. Christian Pasquali, Professor, Geneva Research Center, Merck Serono International S.A., Switzerland

15:50-16:15

Title: Genomewide Identification of Gene-gene Interactions Associated with the Susceptibility to Disease

Dr. Sara Marsal Barril
, Senior Consultant in Rheumatology, Rheumatology Unit, Hospital Universitari Vall d'Hebron, Spain

16:15-16:40

Title: Computational Genetics: Toward Understanding Our Drugs and Diseases

Dr. Guochun Liao, Group Leader, Roche Pharmaceuticals, USA

16:40-17:05

Title: Nutrigenomic and Immunosenescence

Dr. Eugenio Mocchegiani
, Immunology Centre, (Section: Nutrition, Immunity and Ageing). Res. Dept. Italian National Research Centres on Ageing (I.N.R.C.A); Italy.

17:05-17:30 Title: TBD

Dr. Dean W. Felsher, Associate Professor, Stanford University, USA
17:30-17:55 Title: Arsenic Trioxide - Teaching An Old Drug New Tricks

Dr. Meir Wetzler, Chief, Leukemia Section, Roswell Park Cancer Institute, USA
17:55-18:15

Only One Speech Opportunity is Available

Oct.18, 2008
Saturday
13:30-17:30

Session 2: Regenerative Medicine and Drug Discovery

Session Chair:

Dr. Christophe Labie, Head, Neurobiology Group, Sanofi-aventis, Inc., France

Co-Chair:

Dr. Xianmin Zeng, Assistant Professor, Buck Institute for Age Research, USA
13:30-13:55

Title: Polymeric Artificial Cells Containing Stem Cells for Regenerative Medicine

Dr. Thomas Ming Swi Chang,
Director, Artificial Cells & Organs Research Centre, McGill University, Canada

13:55-14:20 Title: Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain

Dr. Christophe Labie, Head, Neurobiology Group, Sanofi-aventis, Inc., France
14:20-14:45

Title: Transdifferentiation of Bone Marrow Stromal Cells into Neuronal Cells and Its
Application for Regenerative Medicine


Dr. Masaaki Kitada, Associate Professor, Department of Stem Cell Biology and Histology, Tohoku Univeristy Graduate School of Medicine, Japan

14:45-15:10

Title: Human Embryonic Stem Cells: the Potential in Drug Discovery

Dr. Xianmin Zeng, Assistant Professor, Buck Institute for Age Research, USA

15:10-15:25 Coffee Break
15:25-15:50

Title: Stem cells and Regenerative Medicine

Dr. Michele De Luca, Full Professor of Biochemistry and Director, Centre for Regenerative Medicine, Department of Biomedical Sciences, University of Modena and Reggio Emilia, Italy

15:50-16:15
Title: TBD

Dr. Hui Zhen Sheng, Laboratory of Stem Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China.
16:15-16:40 Title: Development of Cellular Models for alpha-synuclein Dependent Neurodegeneration

Dr. Poul Henning Jensen, Head, Professor, University of Aarhus, Denmark
16:40-17:05 Title: TBD

Dr. Debu Banerjee, Associate Professor of Medicine, Pharmacology Department, Robert Wood Johnson Medical School, The University of Medicine & Dentistry of New Jersey, USA
17:05-17:30 Title: TBD

Dr. Rong-Tsun Wu
, Professor & Director, Research Center for Drug Discovery, Institute of Biopharmaceutical Science, National Yang-Ming University, Taiwan
17:30-17:50 Only One Speech Opportunity is Available
17:50-18:00

Panel Discussion

3-5 topics will be proposed by Session Chair

Oct.18, 2008
Saturday
13:30-17:30

Session 3: Molecular/Cell Biology and Drug Discovery

Session Chair:

Dr. Michael R. Briggs, Senior Director and Head of Cell & Molecular Biology, Vertex Pharmaceuticals, Inc., USA

Co-Chair:

Dr. Jingwen Liu, Principal Investigator, VA Palo Alto Health Care System, USA
13:30-13:50

Title: Finding Novel Cancer Drugs that Address Unmet Medical Needs

Dr. Michael R. Briggs,
Senior Director and Head of Cell & Molecular Biology, Vertex Pharmaceuticals, Inc., USA

13:50-14:10

Title: P25/CDK5 Inhibitors for AD Therapeutics

Dr. Ilho Ha, Director, BioScience Center Hanwha Chemical R&D Institute Hanwha Chemical Co., Korea

14:10-14:30 Title: DNA polymerase inhibitors for HBV therapy

Dr. Howard Li
, Vertex Pharmaceuticals, Inc., USA
14:30-14:50

Title: TBD

Dr. Huichuan Sun,
Porfessor, Liver Cancer Institute of Fudan University, China

14:50-15:05 Coffee Break
15:05-15:25

Title: Peptide Inhibitors of Metastasis in Liver Cancer

Dr. Yinkun Liu,
Deputy Director, Liver Cancer Institute of Fudan University, China

15:25-15:45

Title: The Identifications of the Molecular Targets for Berberine Mediated Cholesterol Reduction in Plasma and in Liver

Dr. Jingwen Liu,
Principal Investigator, VA Palo Alto Health Care System, USA

15:45-16:05 Title: Wisdom: Grid Computing Enabled Identification of Active Molecules against Targets Implicated in Malaria

Dr. Vincent Breton,
Research Associate, CNRS-IN2P3 Laboratory, France
16:05-16:25

Title: The mosquito Sodium Channel: Adaptive Changes of Amino Acid and Codon Biases in the Evolution of Pyrethroid Resistance

Dr. Nannan Liu, Associate professor, Department of Entomology and Plant Pathology, Auburn University, Auburn, USA

16:25-16:45 Title: Novel Technologies for Expediting Drug Discovery Research

Dr. Keming Song, R&D Manager, Sigma-Aldrich Corporation, USA
16:45-17:05

Title: TBD

Dr. Ban H Tan
, MRCP ( UK ) Head, Dept of Infectious Diseases Singapore General Hospital, Singapore

17:05-17:25

Only One Speech Opportunity is Available

Oct.18, 2008
Saturday
13:30-17:30

Session 4: Immunology and Drug Discovery

Session Chair:

Dr. Prakash Nagarkatti, Associate Dean for Basic Science, University of South Carolina School of Medicine, USA

Co-Chair:

Call for Co-Host
13:30-13:55

Title: Use of Cannabinoids as Novel Anti-inflammatory Drugs through Potential Targeting of CB2 Receptors

Dr. Prakash Nagarkatti,
Associate Dean for Basic Sciences, University of South Carolina School of Medicine, USA

13:55-14:20 Title: Control of T cell Cytokine Profile during Pregnancy

Dr. Marie-Pierre Piccinni
, Professor, University of Florence, Italy
14:20-14:45

Title: TBD

Dr Sofia Kalaboka, Pediatrician ¨C Allergist, DU Immunotherapy, DU Eating Disorders, France
14:45-15:10

Title: The Interleukin-6 Inflammation Pathway from Cholesterol to Aging ¨C Role of Statins, Bisphosphonates and Plant Polyphenols in Aging and Age-related Diseases

Dr. Sota Omoigui, Director, Division of Inflammation and Pain Medicine, L.A Pain Clinic, USA

15:10-15:25 Coffee Break
15:25-15:50

Title: Neural Mechanism Involved in Chagas Cardiomyooathy: From Neurogenic to Immunogenic Trophic Theories

Dr. Rafael Bonfante-Cabarcas,
Director of Biomedical Science PhD Program, Department of Functional Science, School of Medicine, Universidad Cent occidental "Lisandro Alvarado", Venezuela

15:50-16:15

Title: TBD

Dr. Yasmin Thanavala, Professor and Member, Roswell Park Cancer Institute, USA
16:15-16:40

Title: Ligand-Mediated Targeting of Therapeutic Agents to Cancer Tissues and Sites of Inflammation

Dr. Philip S. Low, Ralph C. Corley Distinguished Professor, Department of Chemistry, Purdue University, USA

16:40-17:05

Title: TBD

Dr. Ana Paula de Mattos Areas, Natural and Human Sciences Center, Federal University of ABC, Brazil
17:05-17:30 Only One Speech Opportunity is Available
17:30-17:50

Panel Discussion

3-5 topics will be proposed by Session Chair

Oct.18, 2008
Saturday
13:30-17:30

Session 5: Oncology and Drug Discovery

Session Chair:

Dr. Mitzi Nagarkatti, Deputy Director of Cancer, University of South Carolina, USA

Co-Chair:

Dr. M. Asif Chaudry, University Department of Surgery Royal Free & University College London, UK

13:30-13:55

Title: Tumor-Selective Anticancer Drugs from Amphiphilic Organophosphazenes

Dr. Youn Soo Sohn,
Distinguished Professor, Department of Chemistry, Division of Nano Science, Ewha Womans University, Korea

13:55-14:20

Title: Targeting the Cannabinoid System as a Novel Therapeutic Modality to Treat Cancers of the Immune System

Dr. Mitzi Nagarkatti,
Deputy Director of Cancer, University of South Carolina, USA

14:20-14:45

Title: Fragment Based Drug Discovery Using Rational Design

Dr. Harren Jhoti,
Chief Executive Officer, Astex Therapeutics, Cambridge, UK

14:45-15:10

Title: Multifunctional Antibody Treatment Targeting EpCAM in GI

Dr. M Asif Chaudry,
University Department of Surgery Royal Free & University College London, UK

15:10-15:25 Coffee Break
15:25-15:50

Title: Membrane Transporters in Oncology Drug Discovery

Dr. Laszlo Homolya,
Senior Scientist, Research Group for Membrane Biology, Semmelweis¡¡University, Hungarian Academy of Sciences, Hungary

15:50-16:15

Title: Targeting Multidrug Resistant Cancer

Dr. Gergely Szak¨¢cs,
Professor, Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary

16:15-16:40

Title: Target Therapy in Cancer

Dr. Valentina Tzekova, Professor, University Hospital ¡°Queen Joanna¡±, Bulgaria

16:40-17:05

Title: Solasodine Rhamnosyl Glycosides a New Treatment for Skin Cancer
and New Hope for Other Cancers from Nature's Pharmacy


Dr. Bill E Cham, Biochemist, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Queensland, Australia

17:05-17:30

Title: Identification of Cyano Indenopyrazine Derivatives as a Novel Series of Potent Ubiquitin-Specific Protease Inhibitors

Dr. Fr¨¦d¨¦ric Colland, Director, Biological Research, Hybrigenics, France

17:30-17:50 Only One Speech Opportunity is Available

Oct.18, 2008
Saturday
13:30-17:30

Session 6: Microbiology, Virology and Drug Discovery

Session Chair:

Call for Host

Co-Chair:

Dr. Grace Wong, Founder, President & CSO, ActoKine Therapeutics, USA
13:30-13:55 Keynote Speaker

Title:
Discovering Enteric Dialysis ¨C The Gut Based Uremia Therapy for Chronic Kidney Failure Applications


Dr. Natarajan Ranganathan, Interim CEO, Kibow Biotech, USA
13:55-14:20

Title: TBD

Dr. Ivan Diamond, Vice-President, Neuroscience, CV Therapeutics, Inc., USA
14:20-14:45

Title: Identification of AK-1 for Oxidative Stress and AK-2 for Protection against a Broad-spectrum Viral Infection

Dr. Grace Wong, Founder, President & CSO, ActoKine Therapeutics, USA
14:45-15:10

Title: TBD

Dr. Michael Bukrinsky,
Professor and Vice Chair, The George Washington University, USA

15:10-15:25 Coffee Break
15:25-15:50

Title: TBD

Dr. Mia Levite, Senior Scientist/Lecturer, The Weizmann Institute of Science, Israel

15:50-16:15

Title: A System-biology Based Examination of Antibiotic Resistance toward New Therapy Development

Dr. Hsun-Cheng Su, Ph.D. Research Associate, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, USA

16:15-16:40

Title: Low cost integral aproaches for Pertussis Vaccines for Neonates, Infants and Adolecents developed at Instituto Butantan - Brazil

Dr. Luciana C.C. Leite, Centro de Biotecnologia, Instituto Butantan, Brasil

16:40-17:05

Title: TBD

Dr. Terje Pedersen, Centre for Preventive Medicine, Ullev?l University Hospital, University of Oslo, Norway

17:05-17:30

Only One Speech Opportunity is Available

17:30-17:50

Panel Discussion

3-5 topics will be proposed by Session Chair

Oct.18, 2008
Saturday
13:30-17:30

Session 7: Neurology and Drug Discovery

Session Chair:

Dr. Adrian Newman-Tancredi, Director, Neurobiology 2 Division, Institut de Recherche Pierre Fabre, France

Co-Chair:

Dr. Xueqing Wang, Associate Research Investigator, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, USA
13:30-13:50

Title: Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases): What can be Learned by Studies on Cu(II)-peptide Complexes

Dr. Gianni Valensin,
Professor, Director of the NMR Centre of the University of Siena, Italy

13:50-14:10

Title: Opioid Antagonist Treatment and Alcohol Consumption: Role of Dose, Gender and Pharmacologic Strategy

Dr. Jorge Ju¨¢rez,
Professor, Universidad de Guadalajara, M¨¦xico

14:10-14:30

Title: TCA Cycle May Play an Important Role for Protection Against Epileptic Seizures

Dr. Hiro-aki Yamamoto,
Associate Professor, University of Tsukuba, Japan

14:30-14:50

Title: Serotonin 5-HT 1A Receptors : How New Mechanisms are Driving Innovation and Drug Discovery

Dr. Adrian Newman-Tancredi,
Director, Neurobiology 2 Division, Institut de Recherche Pierre Fabre, France

14:50-15:05 Coffee Break
15:05-15:25

Title: Neurovascular Dysfunction in Dementia: Cholinesterase Inhibitors

Dr. Sabina Janciauskiene, Lund University, Department of Clinical Sciences, Sweden

15:25-15:45

Title: TBD

Dr. Jeffrey N. Agar, Chemistry and Neuroscience, Brandeis University

15:45-16:05

Title: TBD

Dr. Rajendra D Badgaiyan
, Assistant Professor, Harvard Medical School, USA

16:05-16:25

Title: Nonhuman Primates as Surrogates for Humans in Predicting Drug Effects on Cognitive Function: Using Identical Behavioral Tasks in Humans and Laboratory Animals

Dr. Merle G. Paule, Director, Division of Neurotoxicology, National Center for Toxicological Research, USA

16:25-16:45 Title: Investigating Effects of Anesthetics on Bbeta Amyloid Peptide Accumulation and Aggregation, the Key Pathogenic Event in Alzheimer Disease

Dr.
Vincenzo Fodale, Aggregate Professor, University of Messina, Italy
16:45-17:05 Title: TBD

Dr. Xueqing Wang
, Associate Research Investigator, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, USA
17:05-17:25

Title: Kruppel-Like Transcription Factors Regulate Hypothalamic TRH Neuronal Phenotype Differentiation

Dr. Carlos P¨¦rez-Monter, Instituto de Biotecnolog ¨ª a, Departamento de Gen¨¦tica del Desarrollo y Fisiolog ¨ª a Molecular, M¨¦xico

17:25-17:45

Only One Speech Opportunity is Available

Oct.18, 2008
Saturday
13:30-17:30

Session 8: Hepatology and Drug Discovery

Session Chair:


Dr. Michael S Roberts,
Professor, University of Queensland, Australia

Co-Chair:


Dr. Hanry Yu,
Associate Professor, National University of Singapore, Singapore
13:30-13:55 Title: Detecting and Managing pre-clinical Signals of Drug Hepatotoxicity

Dr. Gerry Kenna, Principal Scientist in Molecular Toxicology, AstraZeneca Ltd, UK
13:55-14:20

Title: Drug Structure- Hepatic Pharmacokinetic Relationships in Normal and Diseased Livers

Dr. Michael S Roberts,
Professor, University of Queensland, Australia

14:20-14:45

Title: Chemoembolizattion of Hepatic Neoplasm with Drug-eluting Microspheres

Dr. T. Gregory Walker,
Associa